← Eichor
Study identifier: NCT07629479 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Ejaculation-Preserving Versus Standard Bipolar TUEP for BPH

Condition: Benign Prostatic Hyperplasia · Lower Urinary Tract Symptoms · Benign Prostatic Obstruction  ·  Sponsor: Beni-Suef University

PhaseNA
Planned participants60
Who can joinMale, 50 Years to no upper limit
Healthy volunteersNo

About this study

This prospective randomized controlled trial will compare ejaculation-preserving bipolar transurethral enucleation of the prostate with standard bipolar transurethral enucleation of the prostate in sexually active men with benign prostatic hyperplasia and lower urinary tract symptoms after failed medical treatment. Participants will be randomly assigned to either ejaculation-preserving B-TUEP or standard B-TUEP. The study will evaluate preservation of ejaculatory function, erectile function, urinary symptom improvement, uroflowmetry outcomes, post-void residual urine, perioperative complications, and need for retreatment during follow-up.

This description comes directly from the study's public registry record.

Talk to the study team

Hany F Badawy, MD  ·  +201149525028  ·  HANYFATHY86@GMAIL.COM

Always discuss trial participation with your own doctor first.

Locations (1)

Department of Urology- Beni-Suef University HospitalsBanī Suwayf, Beni Suweif Governorate, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07629479